BNP Paribas Financial Markets
IDYA icon

BNP Paribas Financial Markets’s IDEAYA Biosciences IDYA Stock Holding History

BNP Paribas Financial Markets’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$811K Sell
21,754
-11,470
-35% -$351K ﹤0.01% 3460
2026
Q1 		$1.11M Buy
33,224
+15,040
+83% +$505K ﹤0.01% 3067
2025
Q4 		$629K Buy
18,184
+1,471
+9% +$46.9K ﹤0.01% 3444
2025
Q3 		$455K Sell
16,713
-42,493
-72% -$1.03M ﹤0.01% 3587
2025
Q2 		$1.24M Sell
59,206
-65,011
-52% -$1.25M ﹤0.01% 2781
2025
Q1 		$2.03M Buy
124,217
+85,525
+221% +$1.82M ﹤0.01% 2354
2024
Q4 		$994K Buy
38,692
+10,543
+37% +$298K ﹤0.01% 2833
2024
Q3 		$892K Sell
28,149
-46,315
-62% -$1.76M ﹤0.01% 2566
2024
Q2 		$2.61M Sell
74,464
-48,551
-39% -$1.92M ﹤0.01% 1763
2024
Q1 		$5.4M Sell
123,015
-84,720
-41% -$3.64M ﹤0.01% 1410
2023
Q4 		$7.39M Buy
207,735
+155,179
+295% +$4.63M 0.01% 1197
2023
Q3 		$1.42M Buy
52,556
+8,238
+19% +$209K ﹤0.01% 2105
2023
Q2 		$1.04M Sell
44,318
-12,374
-22% -$254K ﹤0.01% 2174
2023
Q1 		$778K Buy
56,692
+17,084
+43% +$285K ﹤0.01% 2475
2022
Q4 		$720K Sell
39,608
-13,733
-26% -$231K ﹤0.01% 2365
2022
Q3 		$796K Buy
53,341
+44,768
+522% +$581K ﹤0.01% 2658
2022
Q2 		$118K Buy
8,573
+4,480
+109% +$49.8K ﹤0.01% 3298
2022
Q1 		$45.8K Sell
4,093
-6,901
-63% -$102K ﹤0.01% 3572
2021
Q4 		$260K Buy
10,994
+3,940
+56% +$91.5K ﹤0.01% 3291
2021
Q3 		$180K Buy
7,054
+5,655
+404% +$132K ﹤0.01% 3078
2021
Q2 		$29.4K Sell
1,399
-5,286
-79% -$109K ﹤0.01% 3436
2021
Q1 		$157K Buy
6,685
+2,808
+72% +$54.2K ﹤0.01% 3149
2020
Q4 		$54.3K Buy
3,877
+199
+5% +$2.7K ﹤0.01% 3517
2020
Q3 		$46.2K Buy
3,678
+3,227
+716% +$40K ﹤0.01% 3499
2020
Q2 		$6.41K Buy
+451
New +$3.55K ﹤0.01% 3898

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

BNP Paribas Financial Markets's IDYA Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its IDEAYA Biosciences (IDYA) stake by 35% in Q2 2026, selling an estimated $351K and leaving 21,754 shares worth $811K. The position accounts for ﹤0.01% of the portfolio, ranked #3460.

BNP Paribas Financial Markets first reported a position in IDYA in Q2 2020 and has held it in 25 quarters since. The position peaked at $7.39M in Q4 2023. 285 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • BNP Paribas Financial Markets held 21,754 shares of IDEAYA Biosciences worth $811K as of Q2 2026.
  • BNP Paribas Financial Markets sold 11,470 IDEAYA Biosciences shares in Q2 2026, an estimated $351K.
  • IDEAYA Biosciences made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #3460 holding.
  • BNP Paribas Financial Markets first reported a position in IDEAYA Biosciences in Q2 2020 and has held it in 25 quarters since.
  • BNP Paribas Financial Markets's IDEAYA Biosciences position peaked at $7.39M in Q4 2023.
  • 285 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.